New means to assess neonatal inflammatory brain injury

Chen Jin1, Irene Londono2, Carina Mallard3

  • 1Department of Pediatrics, Sainte-Justine Hospital and Research Center, Université de Montréal, 3175 Chemin de la Côte-Sainte-Catherine, Montréal, Québec, H3T 1C5, Canada. chen.jin@alumni.ubc.ca.

Journal of Neuroinflammation
|September 27, 2015
PubMed

Insights

Preterm infants face high risks of brain injury from infections, leading to long-term neurological issues. Early detection and neuroprotection are crucial, with MRI showing promise for monitoring.

Area of Science:

  • Neonatal neurology
  • Neuroinflammation
  • Developmental neuroscience

Background:

  • Preterm infants are susceptible to infection-induced white matter injury, linked to cerebral palsy and cognitive deficits.
  • The injury mechanisms involve microglial activation, inflammation, excitotoxicity, and oligodendrocyte vulnerability.
  • Adverse neurological outcomes necessitate early detection and effective neuroprotective strategies.

Purpose of the Study:

  • To highlight the vulnerability of preterm infants to infection-induced white matter injury.
  • To discuss the complex mechanisms underlying this brain injury.
  • To emphasize the need for noninvasive monitoring and neuroprotective strategies.

Main Methods:

  • Review of existing literature on infection-induced white matter injury in preterm infants.
  • Discussion of proposed mechanisms including inflammation and excitotoxicity.
  • Evaluation of diagnostic and therapeutic approaches, including biomarkers and MRI.

Main Results:

  • Infection-induced white matter injury in preterm infants leads to significant neurological impairments.
  • Multiple pathways contribute to brain damage, including inflammatory responses and excitotoxicity.
  • Noninvasive methods like MRI show potential for monitoring disease progression and treatment efficacy.

Conclusions:

  • Urgent need for early detection and neuroprotective interventions for infection-related brain injury in preterm infants.
  • Magnetic resonance imaging (MRI) is a promising noninvasive tool for monitoring.
  • Further clinical trials are needed to translate promising preclinical findings into effective therapies.

Related Concept Videos